Medicines Company Receives Marketing Approval For EU Commission

Medicines Co. (MDCO: Quote) Monday said it received marketing authorization from European Commission for three of its hospital acute care products - Kengrexal, Orbactiv, and Raplixa. Earlier in January, these products has received positive opinions from ... ..

via News Feed